Biotech stocks enjoyed strong hype and trajectories in the recent past, especially during the pandemic years. Find out why the sector isn't very attractive now.
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue.